gatifloxacin has been researched along with Cronobacter Infections in 4 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quiroga, MP | 1 |
| Andres, P | 1 |
| Petroni, A | 1 |
| Soler Bistué, AJ | 1 |
| Guerriero, L | 1 |
| Vargas, LJ | 1 |
| Zorreguieta, A | 1 |
| Tokumoto, M | 1 |
| Quiroga, C | 1 |
| Tolmasky, ME | 1 |
| Galas, M | 1 |
| Centrón, D | 1 |
| Kletke, SN | 1 |
| Brissette, AR | 1 |
| Gale, J | 1 |
| Ambrose, PG | 1 |
| Anon, JB | 1 |
| Owen, JS | 1 |
| Van Wart, S | 1 |
| McPhee, ME | 1 |
| Bhavnani, SM | 1 |
| Piedmonte, M | 1 |
| Jones, RN | 1 |
| Rondina, MT | 1 |
| Raphael, K | 1 |
| Pendleton, R | 1 |
| Sande, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-Label Noncomparative, Multicenter, Clinical Trail Measuring Time Related Clinical Response Factors in Relation to Time to Bacterial Eradication With Tigecycline Treatment in Patients With Catheter Infection[NCT00419991] | Phase 4 | 10 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for gatifloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis.
Topics: Acute Disease; Anti-Bacterial Agents; Coagulase; Enterobacter aerogenes; Enterobacteriaceae Infectio | 2004 |
3 other studies available for gatifloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross I | 2007 |
Endogenous bacterial endophthalmitis caused by Pantoea species: a case report.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Endophthalmit | 2014 |
Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review.
Topics: Aged; Aorta, Abdominal; Aortitis; Coronary Angiography; Enterobacter aerogenes; Enterobacteriaceae I | 2006 |